risk-groups-and-factors-synagis-survey

This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

Do you wish to continue?

Cancel Continue

Thank you for visiting the AstraZeneca Medicines website

Do you wish to continue?

Cancel Continue

AstraZeneca EduGate

This website is intended for doctors, nurses, and pharmacists in GCC countries. Others please visit www.astrazeneca.com.

Additional Info

Legal Notice and Terms of Use
Privacy Notice
Cookie Policy

Contact AstraZeneca

Contact Us
Report Adverse Event

Adverse events should be reported. Reporting forms and information can be found at aereporting.astrazeneca.com. Adverse events should also be reported to AstraZeneca Saudi on +966112249235 / email at ksa.ae@astrazeneca.com

Approval Code: SA-2772 / Y1-1123

For Gulf
For Medical information Enquires
Website: https://contactazmedical.astrazeneca.com
E-mail: gulf-medicalinfo@astrazeneca.com
Tel: +971 43624888

For Reporting Adverse events and/or Product Quality Complains:
Website: https://contactazmedical.astrazeneca.com
E-mail: Patientsafety-azgulf@astrazeneca.com
Call AstraZeneca FZ LLC land line: +97143624888.

For Saudi Arabia
For Medical information Enquires
Website: https://contactazmedical.astrazeneca.com
E-mail: medinfo-ksa@astrazeneca.com

Al-Nakhla Tower - Floor 13th Ath Thumamah, Road - Al
Sahafa District. 7198 Unit No. 20 Riyadh 13315 – 3642.
Tel: +966 (011) 22 492 00
Fax: +966 (011) 22 492 91

Configure Footer Reference Component

Reference